IDXX241018C840000
- 0.05
- 0.000.00%
IDEXX Laboratories Inc Newsroom
IDEXX Labs Is Maintained at Hold by Stifel
IDEXX Laboratories Analyst Ratings
Stifel Maintains IDEXX Laboratories Inc(IDXX.US) With Hold Rating, Cuts Target Price to $500
BofA Securities Maintains IDEXX Laboratories Inc(IDXX.US) With Hold Rating, Maintains Target Price $550
Morgan Stanley Maintains IDEXX Laboratories Inc(IDXX.US) With Buy Rating, Maintains Target Price $589
BTIG Maintains IDEXX Laboratories Inc(IDXX.US) With Buy Rating, Maintains Target Price $580
IDEXX Laboratories Analyst Ratings
Piper Sandler Maintains Neutral on IDEXX Laboratories, Lowers Price Target to $520
BNP Paribas Exane Adjusts Price Target on IDEXX Laboratories to $607 From $641
Piper Sandler Maintains IDEXX Laboratories Inc(IDXX.US) With Hold Rating, Cuts Target Price to $520
BofA Securities Maintains IDEXX Laboratories Inc(IDXX.US) With Hold Rating, Cuts Target Price to $550
Barclays Maintains IDEXX Laboratories Inc(IDXX.US) With Buy Rating, Maintains Target Price $570
Barclays Maintains IDEXX Laboratories Inc(IDXX.US) With Buy Rating, Maintains Target Price $570
Analyst Ratings For IDEXX Laboratories
IDEXX Labs Price Target Announced at $580.00/Share by BTIG
IDEXX Laboratories Analyst Ratings
BTIG Initiates Coverage On IDEXX Laboratories With Buy Rating, Announces Price Target of $580
BTIG Starts IDEXX Laboratories With Buy Rating, $580 Price Target
BTIG Initiates IDEXX Laboratories Inc(IDXX.US) With Buy Rating, Announces Target Price $580
Morgan Stanley Adjusts Price Target on IDEXX Laboratories to $589 From $596, Maintains Overweight Rating